Indeed, accumulation of CCNE either by over-expression or by defective degradation is observed in several types of cancer amongst which are breast, lung, cervix, endometrium, gastrointestinal tract, sarcomas and hematological malignancies such as lymphoma and leukemia (reviewed by Hwang et al.)[38]. This evidence concerns the gene CCNE1 and lymphoma.